Skip to main content

Drug Repurposing Meeting

On November 18th and 19th 2019 we held the first Biochemical Society Drug Repurposing Meeting 

The meeting was held in Birmingham and was enjoyed by all. The plenary talk by Janet Thornton was a highlight of course and many other excellent talks and discussions suggested that there is an emerging need for groups engaged in these activities to meet and talk. A major strength of the programme was the fluid mix of academia and industry leading to a lot of sharing of ideas to get potential repurposed therapies into the clinic.
Intro by Frank Wesselly - Cardiff.


 First talk by Martin Zeidler - Sheffield
Professor Dame Janet Thornton -EBI



Comments

Popular posts from this blog

Dr. Brad Ebanks - Graduation day!

  Well here we are...in some car park area outside the graduation hall. Just like Brad's PhD... starting in the year 2019/20... it's not ideal, but we made it work! Delighted to have been able to see Brad graduate and to meet his family yesterday! These occasions are the absolute highlight of my academic life - Thank you!

We were able to contribute to two articles appearing this month in Science and Nature Aging!

Epigenetic networks and ageing in 348 mammalian species...including our bats!
New research by a Nottingham academic linking the neurodegenerative disease Parkinson’s to changes in a protein in brain mitochondria is to receive support from a prestigious US funding agency. Dr Lisa Chakrabarti, at The University of Nottingham, will receive $75,000 for a one-year research project from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), which is dedicated to finding a cure for Parkinson’s and funds promising research that could result in new treatments to slow, stop or reverse the progression of the disease. Dr Chakrabarti said: “We are trying to look at mitochondrial biology from a totally different perspective, which could have important implications for Parkinson’s and other neurodegenerative diseases. The funding from The Michael J. Fox Foundation will help us to confirm whether some of the protein changes we see in Parkinson’s are related to disease course.” http://exchange.nottingham.ac.uk/research/parkinsons-study-receives-fu